Already registered? Login below:
This webinar aim to raise awareness and understanding about sepsis.
Topics to be covered include:
Simon Finfer is a Professorial Fellow in the Critical Care Division at The George Institute for Global Health and an Adjunct Professor at the University of New South Wales. He is a practicing critical care physician as a Senior Staff Specialist at Royal North Shore Hospital and Director of Intensive Care at the Sydney Adventist Hospital.
Simon is a member of the Global Sepsis Alliance Executive Board, and the council of the International Sepsis Forum. He founded and is Director of the Australian Sepsis Network and in 2017 initiated the formation of the Asia Pacific Sepsis Alliance. Simon’s major research interest has been the design and conduct of large scale randomised controlled trials in critical care. Increasingly his research focusses on reducing the global burden of sepsis. He has obtained over $50M in research funding and authored or co-authored over 160 peer reviewed papers with 20% of those in the highest-ranking medical journals. He served as a guest editor for the New England Journal of Medicine from 2012 to 2014.
Dr Brett Abbenbroek
Dr Brett Abbenbroek (RN, BSc, MPH, PhD) is the Australian Sepsis Network Program Manager within the Critical Care Division at The George Institute for Global Health, Sydney. Brett has extensive critical care clinical, education and management experience. Brett’s PhD considered the efficiency and effectiveness of critical care organisational models, and the association with patient and nurse outcomes. Study findings aim to inform the Australasian Health Facility Guidelines for new and redeveloped ICUs.
Brett has worked in Nepal, Vanuatu, China and Croatia on projects to establish cardiac surgical and critical care programs, and system-wide service improvements. Concurrently, Brett has held a range of health policy, planning, project management, digital health and clinical safety advisory roles. As the coordinator for state wide clinical service planning for ICU, ED and medical retrieval services he worked with clinicians to develop and enhance the integration of critical care services across NSW. A health service planning and management consultancy business followed, leading to project manager roles within the Australian Commission on Safety and Quality in Health Care on a series of national eHealth clinical safety programs, electronic medication safety and the development of evidence based national clinical care standards.
Mary is a Senior Improvement Lead in the Adult Patient Safety Program at the NSW Clinical Excellence Commission (CEC) and leads the state wide SEPSIS KILLS program. Since 2010 she has been involved in all aspects of program development and roll out and has developed strong networks across the NSW health system. Throughout this time Mary has worked collaboratively with interjurisdictional, national and international organisations to improve sepsis care.
Mary has a clinical background as a Registered Nurse and has worked in the United Kingdom and Australia in intensive care and education prior to moving to the quality and safety arena. She has broad experience in clinical governance and quality/safety improvement at hospital, local health district and state-wide levels and has a strong interest in healthcare culture change and large systems improvement.
Associate Professor Luregn Schlapbach
Luregn Schlapbach is Associate Professor at the University of Queensland and Senior Staff Specialist in the 36-bed multidisciplinary PICU at Queensland Children`s Hospital in Brisbane, Australia. He is the the medical lead of the Paediatric Critical Care Research Group (PCCRG) at the Child Health Research Centre. He holds a NHMRC Practitioner Fellowship on Sepsis, Infection, and Inflammation in Critically Ill Children and is current Chair of the ANZICS Paediatric Study Group. Luregn is group head on the Pediatric Surviving Sepsis Campaign, Co-Chair of the international Paediatric Sepsis Definition Taskforce, and the paediatric lead for the Queensland Sepsis Collaborative. He has been leading observational, genomic, and interventional pediatric sepsis studies and is involved in international consortia on life-threatening childhood infections. Luregn is in the steering board of several NHMRC funded paediatric interventional trials.
Luregn`s research has focused on sepsis and life-threatening infections in critically ill neonates and children, including aspects such as epidemiology, sepsis markers, outcomes and genomics in this highly vulnerable patient group. He is interested in improving our understanding of why some children become critically unwell because of infections, and in developing better approaches to allow early recognition and targeted treatment of sepsis and severe infections in children.
For technical assistance, please phone Redback Connect on 1800 733 416.
Click here to test your system before the webinar.